Announces “Stalking Horse” Agreement for the Sale of Zokinvy® (lonafarnib) Patient Access to Zokinvy® to Continue Uninterrupted PALO ALTO, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Eiger...
Eiger and Partner, AnGes, Receive Approval for Zokinvy® (lonafarnib) for Hutchinson- Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies in Japan PR Newswire PALO ALTO...
Eiger BioPharmaceuticals, Inc. Announces 1-for-30 Reverse Stock Split PR Newswire PALO ALTO, Calif., Jan. 4, 2024 PALO ALTO, Calif., Jan. 4, 2024 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | -5.035 | -74.4822485207 | 6.76 | 8.2672 | 1.1 | 125488 | 2.07593487 | CS |
52 | -21.42 | -92.5469863901 | 23.145 | 28.5 | 1.1 | 238710 | 10.23866482 | CS |
156 | -247.275 | -99.3072289157 | 249 | 300.639 | 1.1 | 446632 | 117.54821722 | CS |
260 | -322.275 | -99.4675925926 | 324 | 474.6 | 1.1 | 387579 | 181.37591535 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.